Compare AYTU & FIEE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AYTU | FIEE |
|---|---|---|
| Founded | N/A | 1977 |
| Country | United States | Hong Kong |
| Employees | N/A | 30 |
| Industry | Biotechnology: Pharmaceutical Preparations | Telecommunications Equipment |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.4M | 31.3M |
| IPO Year | 2015 | 2010 |
| Metric | AYTU | FIEE |
|---|---|---|
| Price | $2.01 | $3.30 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $9.67 | N/A |
| AVG Volume (30 Days) | ★ 40.1K | 3.0K |
| Earning Date | 11-12-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 107.46 |
| EPS | N/A | ★ 0.17 |
| Revenue | $27,632,080.00 | ★ $47,988,549.00 |
| Revenue This Year | $17.96 | N/A |
| Revenue Next Year | $27.98 | N/A |
| P/E Ratio | ★ N/A | $18.24 |
| Revenue Growth | ★ 277.47 | 27.58 |
| 52 Week Low | $1.80 | $1.50 |
| 52 Week High | $3.07 | $10.59 |
| Indicator | AYTU | FIEE |
|---|---|---|
| Relative Strength Index (RSI) | 46.93 | 30.35 |
| Support Level | $1.94 | $2.40 |
| Resistance Level | $2.34 | $4.54 |
| Average True Range (ATR) | 0.09 | 0.10 |
| MACD | 0.00 | -0.04 |
| Stochastic Oscillator | 48.55 | 15.15 |
Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline, including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates one business segment consisting of various prescription pharmaceutical products sold through third parties.
FiEE Inc is a digital service provider focused on integrating artificial intelligence (AI) and data analytics into content creation, digital authentication, and brand management. Its business model leverages a cloud-based SaaS platform designed to support clients in developing, managing, and optimizing their digital presence across platforms, including customized graphics and posts, short videos, and editorial calendars aligned with brand goals. Additionally, it offers comprehensive software development and maintenance services, delivering custom software solutions from system design and development to deployment and post-launch maintenance. It services consist of three core areas: digital content and MCN services, software development services, and digital authentication services.